TABLE 4.
Distribution of emm types among antimicrobial resistant invasive group A streptococcal isolates in Alaska by time perioda
| Time period | No. of isolates | Tetr |
Eryr |
Tetr Eryr |
Eryr Cmr |
Tetr Eryr Cmr |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of isolates | emm type(s) (no. of isolates) | No. of isolates | emm type(s) (no. of isolates) | No. of isolates | emm type(s) (no. of isolates) | No. of isolates | emm type (no. of isolates) | No. of isolates | emm types (no. of isolates) | ||
| 2004–2005 | 48 | 9 | 41, 87 (8) | 0 | NA | 1 | 58 | 1 | 92 | 0 | NA |
| 2006–2009 | 112 | 16 | 1, 41, 49 (4), 87 (4), 108 (6) | 5 | 92 | 5 | 58 (4), 94 | 0 | NA | 0 | NA |
| 2010–2013 | 183 | 2 | 44, stG6.0 | 3 | 3, 75 (2) | 2 | 58 | 0 | NA | 3 | 11 (2), 94 |
a
Tet, tetracycline; Ery, erythromycin; Cm, clindamycin; NA, not applicable.